← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2014Last known activity
Feb 28, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (7 distinct, 5 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Indications
Studied for
Recent trials (8)
- NCT06750757Sponsor investigatorPhase 4Feb 28, 2025
- NCT06750757Lead sponsorPhase 4Feb 28, 2025
- NCT06608914Lead sponsorPhase 4Nov 30, 2024
- NCT06462482Lead sponsorPhase 4Aug 31, 2024
- NCT05722301Lead sponsorPhase 3Nov 1, 2019
- NCT03001453Overall official - principal investigatorPhase 2Apr 1, 2014
- NCT03001453Reponsible party - principal investigatorPhase 2Apr 1, 2014
- NCT03001453Lead sponsorPhase 2Apr 1, 2014
Details
- Last known activity
- Feb 28, 2025